Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 37, 2002 - Issue 6
Submit an article Journal homepage
42
Views
6
CrossRef citations to date
0
Altmetric
Research Article

pH-Activated Phospholipase A 2 : an Important Mucosal Barrier Breaker in Peptic Ulcer Disease

A. E. Berstad
,
K. Berstad
&
A. Berstad
Pages 738-742 | Published online: 08 Jul 2009

  • Peek RM, Jr., Blaser MJ. Pathophysiology of Helicobacter pylori-induced gastritis and peptic ulcer disease. Am J Med 1997:102:200-7.
  • Slomiany BL, Sarosiek J, Slomiany A. Gastric mucus and the mucosal barrier. Dig Dis 1987;5:125-45.
  • Jordan N, Newton J, Pearson J, Alien A. A novel method for the visualization of the in situ mucus layer in rat and man. Clin Sci 1998:95:97-106.
  • Hills BA. Gastric surfactant and the Hydrophobie mucosal barrier. Gut 1996:39:621-4.
  • Slomiany BL, Sarosiek J, Liau YH, Laszewicz W, Slomiany A. Lysolecithin affects the viscosity, permeability, and peptic susceptibility of gastric mucin. Scand J Gastroenterol 1986;21: 1073-9.
  • Butler BD, Lichtenberge r LM, Hills BA. Distribution of surfactants in the canine gastrointestinal tract and their ability to lubricate. Am J Physiol 1983;244:G645-51.
  • Kao YC, Goddard PJ, Lichtenberge r LM. Morphological effects of aspirin and prostaglandi n on the canine gastric mucosal surface. Analysis with a phospholipid-selective cytochemical stain. Gastroenterology 1990:98:592-606.
  • Mauch F, Bode G, Ditschuneit H, Malfertheiner P. Demonstration of a phospholipid-rich zone in the human gastric epithelium damaged by Helicobacter pylori. Gastroenterology 1993; 105: 1698-704.
  • Hills BA. A physical identity for the gastric mucosal barrier. Med J Aust 1990:153:76-81.
  • Venables CW. Mucus, pepsin, and peptic ulcer. Gut 1986;27: 233-8.
  • Pearson J, Alien A, Venables C. Gastric mucus: isolation and polymeric structure of the undegraded glycoprotein : its breakdown by pepsin. Gastroenterology 1980;78:709-15.
  • Scawen M, Alien A. The action of proteolytic enzymes on the glycoprotein from pig gastric mucus. Biochem J 1977;163: 363-8.
  • Sarosiek J, Murty VL, Nadziejko C, Slomiany A, Slomiany BL. Prostaglandin effect on the physical properties of gastric mucus glycoprotein and its susceptibility to pepsin. Prostaglandin s 1986:32:635-46.
  • Bell AE, Sellers LA, Alien A, Cunliffe WJ, Morris ER, RossMurphy SB. Properties of gastric and duodenal mucus: effect of proteolysis, disulfide reduction, bile, acid, ethanol, and hypertonicity on mucus gel structure. Gastroenterology 1985;88:269-80.
  • Hills BA, Butler BD, Lichtenberge r LM. Gastric mucosal barrier: hydrophobia lining to the lumen of the stomach. Am J Physiol 1983;244:G561 -8.
  • Lichtenberge r LM, Wang ZM, Romero JJ, Ulloa C, Perez JC, Giraud MN, et al. Non-steroidal anti-inflammatory drugs (NSADDs) associate with zwitterionic phospholipids : insight into the mechanism and reversal of NSAID-induced gastrointestinal injury. Nature Medicine 1995;l:154-8.
  • Lichtenberge r LM, Ulloa C, Romero JJ, Vanous AL, IIlich PA, Dial EJ. Nonsteroidal anti-inflammatory drug and phospholipid prodrugs: combination therapy with antisecretory agents in rats. Gastroenterology 1996;111:990-5.
  • Lichtenberger LM, Graziani LA, Dial EJ, Butler BD, Hills BA. Role of surface-active phospholipids in gastric cytoprotection. Science 1983;219:1327-9.
  • Sippy BW. Gastric and duodenal ulcer. JAMA 1915;64:1625-30.
  • Kivinen A, Tarpila S, Kiviluoto T, Mustonen H, Kivilaakso E. Milk and egg phospholipids act as protective surfactants against luminal acid in Necturus gastric mucosa. Aliment Pharmacol Ther 1995;9:685-91.
  • Hills BA, Kirwood CA. Surfactant approach to the gastric mucosal barrier: protection of rats by banana even when acidified. Gastroenterology 1989;97:294-303.
  • Lichtenberger LM, Richards JE, Hills BA. Effect of 16,16dimethyl prostaglandin E2 on the surface hydrophobicity of aspirin-treated canine gastric mucosa. Gastroenterology 1985;88: 308-14.
  • Slomiany BL, Nishikawa H, Piotrowski J, Okazaki K, Slomiany A. Lipolytic activity of Campylobacter pylori: effect of sofalcone. Digestion 1989;43:33-40.
  • Newton JL, Jordan N, Oliver L, Strugala V, Pearson J, James OF, et al. Helicobacter pylori in vivo causes structural changes in the adherent gastric mucus layer but barrier thickness is not compromised. Gut 1998;43:470-5.
  • Goggin PM, Marrero JM, Spychal RT, Jackson PA, Corbishley CM, Northfield TC. Surface hydrophobicity of gastric mucosa in Helicobacte r pylori infection: effect of clearance and eradication. Gastroenterology 1992;103:1486-90.
  • Sarosiek J, Marshall BJ, Peura DA, Hoffman S, Feng T, McCallum RW. Gastroduodenal mucus gel thickness in patients with Helicobacter pylori: a method for assessment of biopsy specimens. Am J Gastroenterol 1991;86:729-34.
  • Newton JL, Jordan N, Pearson J, Williams GV, Alien A, James OF. The adherent gastric antrat and duodenal mucus gel layer thins with advancing age in subjects infected with Helicobacter pylori. Gerontology 2000;46:153-7.
  • Micots I, Augeron C, Laboisse CL, Muzeau F, Megraud F. Mucin exocytosis : a major target for Helicobacter pylori. J Clin Pathol 1993:46:241-5.
  • Slomiany BL, Liau YH, Lopez RA, Piotrowski J, Czajkowski A, Slomiany A. Effect of Helicobacter pylori lipopolysaccharid e on the synthesis of sulfated gastric mucin. Biochem Int 1992;27: 687-97.
  • Kuipers EJ, Thijs JC, Festen HPM. The prevalence of Helicobacter pylori in peptic ulcer disease. Aliment Pharmacol Ther 1995;9 Suppl 259-69.
  • Hentschel E, Brandstatter G, Dragosics B, Hirschl AM, Nemec H, Schutze K, et al. Effect of ranitidine and amoxicillin plus metionidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med 1993;328:308-12.
  • Graham DY, Lew GM, Klein PD, Evans DG, Evans DJJ, Saeed ZA, et al. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study. Ann Intern Med 1992;116:705-8.
  • Wilhelmsen I, Berstad A. Quality of life and relapse of duodenal ulcer before and after eradication of Helicobacter pylori. Scand J Gastroenterol 199429:874-9.
  • van der Hulst RM, Rauws EJ, Koycu B, Keller JJ, Bruno MJ, Tussen JP, et al. Prevention of ulcer recurrenc e after eradication of Helicobacter pylori: a prospective long-term follow-up study. Gastroenterology 1997;113:1082-6.
  • Peterson WL. Gastrin and acid in relation to Helicobacte r pylori. Aliment Pharmacol Ther 1996;10 Suppl 1:97-102.
  • Moss SF, Legon S, Bishop AE, Polak JM, Calam J. Effect of Helicobacter pylori on gastric somatostatin in duodenal ulcer disease. Lancet 1992;340:930-2.
  • Piotrowski J, Majka J, Slomiany A, Slomiany BL. Helicobacter pylori lipopolysaccharid e inhibition of gastric mucosal somatostatin receptor. Biochem MoI Biol Int 1995;36:491 -8.
  • Bendtsen F, Rosenkilde-Gram B, Tage-Jensen U, Ovesen L, Rune SJ. Duodenal bulb acidity in patients with duodenal ulcer. Gastroenterology 1987;93:1263-9.
  • Hausken T, Ødegaard S, Matre K, Berstad A. Antroduodenal motility and movements of luminal contents studied by duplex sonography. Gastroenterology 1992;102:1583-90.
  • Genta RM, Graham DY. Intestinal metaplasia, not atrophy or achlorhydria, creates a hostile environment for Helicobacter pylori. Scand J Gastroenterol 1993;28:924-8.
  • McCoIl KEL, El Omar EM, Gillen D. The role of Helicobacter pylori infection in the pathophysiology of duodenal ulcer disease. J Physiol Pharmacol 1997;48:287-95.
  • Khulusi S, Mendall MA, Badve S, Patel P, Finlayson C, Northfleld TC. Effect of Helicobacter pylori eradication on gastric metaplasia of the duodenum. Gut 1995;36:193-7.
  • Balsinde J, Diez E, Schuller A, Mollinedo F. Phospholipase A2 activity in resting and activated human neutrophils. Substrate specificity, pH dependence, and subcellular localization. J Biol Chem 1988:263:1929-36.
  • Berstad K, Sjfdahl R, Berstad A. Phospholipase A2 activity in gastric juice from patients with active and Helicobacter pylorieradicated healed duodenal ulcer. Aliment Pharmacol Ther 1994; 8:175-80.
  • Berstad K, Berstad A Jr, Sj ødahl R, Weberg R, Berstad A. Eosinophil cat ionic protein and phospholipase A2 activity in human gastric juice. With emphasis on Helicobacter pylori status and effects of antacids. Scand J Gastroenterol 1992;27:1011 -7.
  • Langton SR, Cesareo SD. Helicobacter pylori associated phospholipase A2 activity: a factor in peptic ulcer production? J Clin Pathol 1992;45:221 -4.
  • Murakami M, Nakatani Y, Atsumi G, Inoue K, Kudo I. Regulatory functions of phospholipase A2. Crit Rev Immunol 1997:17:225-83.
  • Rosam A-C, Wallace JL, Whittle BJ. Potent ulcerogenic actions of platelet-activating factor on the stomach. Nature 1986;319: 54-6.
  • Denizot Y, Sobhani I, Rambaud JC, Lewin M, Thomas Y, Benveniste J. Paf-acether synthesis by Helicobacter pylori. Gut 1990:31:1242-5.
  • Dorrell N, Martino MC, Stabler RA, Ward SJ, Zhang ZW, McCoIm AA, et al. Characterization of Helicobacter pylori PIdA, a phospholipase with a role in colonization of the gastric mucosa. Gastroenterology 1999;117:1098-104.
  • Ottlecz A, Romero JJ, Hazell SL, Graham DY, Lichtenberger LM. Phospholipase activity of Helicobacter pylori and its inhibition by bismuth salts. Biochemical and biophysical studies. Dig Dis Sci 1993:38:2071-80.
  • Slomiany BL, Piotrowski J, Slomiany A. Effect of sucralfate on the degradation of human gastric mucus by Helicobacter pylori protease and upases. Am J Gastroenterol 1992:87:595-9.
  • Berstad A. A modified hemoglobin substrate method for the estimation of pepsin in gastric juice. Scand J Gastroenterol 1970; 5:343-8.
  • Hills BA. Gastric mucosal barrier: evidence for Helicobacter pylori ingesting gastric surfactant and deriving protection from it. Gut 1993:34:588-93.
  • Berstad A. Inactivation of human gastric pepsin by duodenal juice. Scand J Gastroenterol 1971;6:241 -4.
  • Hackeisberger A, Platzer U, Nilius M, Schlitze V, Günther T, Dominguez-Munoz JE, et al. Age and Helicobacter pylori decrease gastric mucosal surface hydrophobicity independently. Gut 1998:43:465-9.
  • Oi M, Oshida K, Sugimura S. The location of gastric ulcer. Gastroenterology 1959:36:45-56.
  • Berstad AE, Hatlebakk JG, Maartmann-Moe H, Berstad A, Brandtzaeg P. Helicobacter pylori gastritis and epithelial cell proliferation in patients with reflux oesophagitis after treatment with lansoprazole. Gut 1997:41:740-7.
  • Roland M, Berstad A, Liavâg I. A histological study of gastric mucosa before and after proximal gastric vagotomy in duodenal ulcer patients. Scand J Gastroenterol 1975;10:181 -6.
  • Graham DY, Genta R, Evans DG, Reddy R, Clarridge JE, Olson CA, et al. Helicobacter pylori does not migrate from the antrum to the corpus in response to omeprazole. Am J Gastroenterol 1997:91:2120-4.
  • Ruding R. Gastric ulcer and antrat border. Surgery 1967;61: 495-7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.